Cough clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis
open to eligible people ages 40 years and up
ORV-PF-01 is a two way, placebo controlled, cross-over study, to evaluate the effect of two doses of orvepitant on cough in patients with IPF.
at UCSF
Last updated: